<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="79236">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02073942</url>
  </required_header>
  <id_info>
    <org_study_id>14-050</org_study_id>
    <nct_id>NCT02073942</nct_id>
  </id_info>
  <brief_title>Cologne Register of Wearable Defibrillator (CRWD)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zoll Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cologne</source>
  <brief_summary>
    <textblock>
      The wearable cardiac defibrillator (WCD) is an alternative to the implantation of
      cardioverter defibrillator (ICD) for patients at high risk for sudden cardiac death (mostly
      bridging therapy). The Cologne register of wearable defibrillator (CRWD) is a prospective
      register for all patient with an indication of wearable defibrillator.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Number of arrhythmic events and arrhythmic risk factors during bridging therapy with wearable defibrillator</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total mortality</measure>
    <time_frame>1 months and 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 months and 3 months</time_frame>
    <description>SF-12v2Â® Health Survey questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>1 months and 3 months</time_frame>
    <description>BDI-II questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>1 months and 3 months</time_frame>
    <description>STAI-G Form X1 questionnaire</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Ventricular Dysfunction</condition>
  <condition>Myocarditis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with an indication for wearable defibrillator
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with an indication for wearable defibrillator

        Exclusion Criteria:

          -  childs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guido Michels, Prof. Dr.</last_name>
    <phone>++49-221-478-32401</phone>
    <email>guido.michels@uk-koeln.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roman Pfister, Dr.</last_name>
    <phone>++49-221-478-32401</phone>
    <email>roman.pfister@uk-koeln.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Michels, Prof. Dr.</last_name>
      <phone>++49-221-478-32401</phone>
      <email>guido.michels@uk-koeln.de</email>
    </contact>
    <contact_backup>
      <last_name>Roman Pfister, Dr.</last_name>
      <phone>++49-221-478-32401</phone>
      <email>roman.pfister@uk-koeln.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 24, 2016</lastchanged_date>
  <firstreceived_date>February 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Guido Michels</investigator_full_name>
    <investigator_title>PD Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Myocarditis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
